Kuss; Hildegard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kuss; Hildegard.The latest application filed is for "7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them".

Company Profile

0.10.13

Kuss; Hildegard - Dresden DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
7-azaindoles and the use thereof as therapeutic agents Grant 7,947,705 - Hofgen , et al. May 24, 2	2011-05-24
7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them Grant 7,683,074 - Hofgen , et al. March 23, 2	2010-03-23
Combination of loteprednol and .beta..sub.2-adrenoceptor agonists Grant 7,521,438 - Szelenyi , et al. April 21, 2	2009-04-21
7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them Grant 7,419,987 - Hofgen , et al. September 2, 2	2008-09-02
7-Azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them App 20080207680 - Hofgen; Norbert ; et al.	2008-08-28
Use of the non-opiate analgesic drug flupirtine for the treatment of overactive bladder and associated diseases including urge incontinence, urinary flow problems as a result of prostate hyperplasia and irritable bowel syndrome Grant 7,309,713 - Rundfeldt , et al. December 18, 2	2007-12-18
7-Azaindoles and the use thereof as therapeutic agents App 20070161671 - Hofgen; Nobert ; et al.	2007-07-12
7-azaindoles and the use thereof as therapeutic agents Grant 7,211,583 - Hofgen , et al. May 1, 2	2007-05-01
Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them App 20070093531 - Hofgen; Norbert ; et al.	2007-04-26
7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same Grant 7,169,787 - Hofgen , et al. January 30, 2	2007-01-30
Hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them Grant 7,166,637 - Hofgen , et al. January 23, 2	2007-01-23
7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them App 20060258700 - Hofgen; Norbert ; et al.	2006-11-16
Use of the non-opiate analgesic drug flupirtine of the treatment of overactive bladder and associated diseases including urge incontinence, urinary flow problems as a result of prostate hyperplasia and irritable bowl syndrome App 20060173052 - Rundfeldt; Chris ; et al.	2006-08-03
4-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents Grant 7,067,536 - Hofgen , et al. June 27, 2	2006-06-27
4-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents App 20060128758 - Hofgen; Nobert ; et al.	2006-06-15
5-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents App 20040266760 - Hofgen, Nobert ; et al.	2004-12-30
4-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents App 20040242643 - Hofgen, Nobert ; et al.	2004-12-02
7-azaindoles and the use thereof as therapeutic agents App 20040224971 - Hofgen, Nobert ; et al.	2004-11-11
Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation Grant RE38,624 - Hofgen , et al. October 12, 2	2004-10-12
Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them App 20040147759 - Hofgen, Norbert ; et al.	2004-07-29
Treatment of nonallergic rhinitis by selective phosphodiesterase 4 inhibitors App 20040116501 - Rundfeldt, Chris ; et al.	2004-06-17
Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same App 20040106641 - Hofgen, Norbert ; et al.	2004-06-03
Topical treatment of skin diseases App 20040038958 - Rundfeldt, Chris ; et al.	2004-02-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.